Avmapki Fakzynja Co-Pack (avutometinib capsules; defactinib tablets co-packaged – Verastem) — Cigna
Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Initial criteria
- Patient age ≥ 18 years
- Patient has recurrent low-grade serous cancer
- Cancer has a KRAS mutation
- Patient has tried at least one systemic therapy (e.g., paclitaxel, carboplatin, bevacizumab, letrozole, anastrozole, or exemestane)
Approval duration
1 year